Skip Nav Destination
Issues
1 December 2000
ISSN 1078-0432
EISSN 1557-3265
The Biology Behind
Editorials
Editorial
Advances in Brief
Paclitaxel-induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration: Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment1
W. Fraser Symmans; Matthew D. Volm; Richard L. Shapiro; A. Bridget Perkins; Alice Y. Kim; Sandra Demaria; Herman T. Yee; Heather McMullen; Ruth Oratz; Paula Klein; Silvia C. Formenti; Franco Muggia
Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer
Andrew L. Feldman; Lawrence Tamarkin; Giulio F. Paciotti; Byron W. Simpson; W. Marston Linehan; James C. Yang; William E. Fogler; Ewa M. Turner; H. Richard Alexander, Jr.; Steven K. Libutti
Clinical Trials
Phase I Clinical Trial of the Chimeric Monoclonal Antibody (c30.6) in Patients with Metastatic Colorectal Cancer1
Robyn L. Ward; Deborah Packham; Anne M. Smythe; Jayne Murray; Peter Anderson-Stewart; Neil Kitchen; Rosyln Muirhead; Peter Phillips; Peter Gray; Grant Bigg-Wither; Krishnan Prabakaran; Judy Freund; Michael Fullham; Michele Rule; David Dalley; Alan Meagher; Nicholas J. Hawkins; Glenn M. Smith
A Phase II Study of Razoxane, an Antiangiogenic Topoisomerase II Inhibitor, in Renal Cell Cancer with Assessment of Potential Surrogate Markers of Angiogenesis1
Jeremy P. Braybrooke; Kenneth J. O’Byrne; David J. Propper; Andrew Blann; Mark Saunders; Nicola Dobbs; Cheng Han; Jane Woodhull; Karen Mitchell; Jeremy Crew; Kenneth Smith; Ross Stephens; Trivadi S. Ganesan; Denis C. Talbot; Adrian L. Harris
Clinical Implications of Dihydropyrimidine Dehydrogenase (DPD) Deficiency in Patients with Severe 5-Fluorouracil-associated Toxicity: Identification of New Mutations in the DPD Gene
André B. P. van Kuilenburg; Janet Haasjes; Dick J. Richel; Lida Zoetekouw; Henk Van Lenthe; Ronney A. De Abreu; Jan G. Maring; Peter Vreken; Albert H. van Gennip
Pharmacokinetics and Pharmacodynamics of the Novel Marine-derived Anticancer Agent Ecteinascidin 743 in a Phase I Dose-finding Study1
Charlotte van Kesteren; Esteban Cvitkovic; Adelkrim Taamma; Luis López-Lázaro; Jośe M. Jimeno; Cecilia Guzman; Ron A. A. Mathôt; Jan H. M. Schellens; Jean-Louis Misset; Etienne Brain; Michael J. X. Hillebrand; Hilde Rosing; Jos H. Beijnen
Molecular Oncology, Markers, Clinical Correlates
Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma
Aizen J. Marrogi; William D. Travis; Judith A. Welsh; Mohammed A. Khan; Haress Rahim; Henry Tazelaar; Peter Pairolero; Victor Trastek; James Jett; Neil E. Caporaso; Lance A. Liotta; Curtis C. Harris
A Genetic Epidemiological Study of Hereditary Prostate Cancer (HPC) in Finland: Frequent HPCX Linkage in Families with Late-onset Disease1
Johanna Schleutker; Mika Matikainen; Jeffrey Smith; Pasi Koivisto; Agnes Baffoe-Bonnie; Tommi Kainu; Elizabeth Gillanders; Risto Sankila; Eero Pukkala; John Carpten; Dietrich Stephan; Teuvo Tammela; Michael Brownstein; Joan Bailey-Wilson; Jeffrey Trent; Olli-P. Kallioniemi
Experimental Therapeutics, Preclinical Pharmacology
Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma1
Keiji Inoue; Joel W. Slaton; Paul Perrotte; Darren W. Davis; Christiane J. Bruns; Daniel J. Hicklin; David J. McConkey; Paul Sweeney; Robert Radinsky; Colin P. N. Dinney
Cancer Biology, Immunology, Cytokines
Letter to the Editor
Correspondence re: M. Kondo et al., Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma. Clin. Cancer Res., 5: 4005–4012, 1999.
Tohru Utsunomiya; Mitsuo Shimada; Tatsuya Rikimaru; Keizo Sugimachi; Ken-Ichi Ohkura; Shihoko Kaku; Koji Yamada; Kyushu University ; Ken-Ichi Taguchi
Errata
Advertisement
